DIAGNOSTIC_TEST · Unmapped registry intervention
Diagnostic Test: Sputum DNA methylation analysis
Find medicine records ·
Find other trials using this name
Clinical trial
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
NCT05337163
Study summary
ClinicalTrials.govA Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
PROCEDURE · Unmapped registry intervention
chest CT or pathological examination
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Adenocarcinomaverified · MONDO: adenocarcinoma
Respiratory Tract Infectionunresolved
Acute Bronchitisunresolved
Pneumoniaverified · MONDO: pneumonia
Chronic Bronchitisverified · MONDO: chronic bronchitis
Tuberculosisverified · MONDO: tuberculosis
Lung Neoplasmverified · MONDO: lung neoplasm
Interventions
Diagnostic Test: Sputum DNA methylation analysisDIAGNOSTIC_TEST
chest CT or pathological examinationPROCEDURE
Sponsors & collaborators
Creative Biosciences (Guangzhou) Co., Ltd.lead sponsor
Guangzhou Xiangkang Medical Research Co., Ltd.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05337163 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.